Skip to main content
Novonesis AS logo

Novonesis AS — Investor Relations & Filings

Ticker · NSIS ISIN · DK0060336014 LEI · 529900T6WNZXD2R3JW38 CO Manufacturing
Open in API
Filings indexed 2,308 across all filing types
Latest filing 2017-11-29 Director's Dealing
Country DK Denmark
Listing CO NSIS

About Novonesis AS

https://www.novozymes.com/en

Novonesis is a global biosolutions company formed through the combination of Novozymes and Chr. Hansen. The company develops and produces a broad portfolio of biological solutions, including industrial enzymes, functional proteins, and microorganisms such as cultures, probiotics, and yeast. Its products are utilized in over 30 industries to improve efficiency, sustainability, and product quality. Key markets include food and beverage, where solutions enhance nutrition and reduce waste; human and animal health; agriculture, promoting higher crop yields and animal welfare; and household care, for more effective cleaning. Novonesis applies biotechnological principles to address global challenges in production and consumption, aiming to create more sustainable systems and products.

Recent filings

Filing Released Lang Actions
Director's Dealing 2017
Director's Dealing Classification · 98% confidence The document explicitly discusses 'Trading by management and of close relations to management' and cites 'article 19 in Regulation (EU) No 596/2014' (Market Abuse Regulation). This regulation mandates reporting of transactions by persons discharging managerial responsibilities (PDMRs). The content describes transactions involving company shares (ISIN DK0060336014) by insiders. This directly corresponds to the definition of Director's Dealing (insider trades). The document is very short (976 chars) and directs the user to 'Read the full announcement in PDF', suggesting it is a brief notification rather than the full regulatory filing itself. However, the core subject matter is definitively insider trading reports, which maps precisely to the 'Director's Dealing' category (DIRS). While it could potentially be RNS if it were just a generic announcement wrapper, the specific subject matter strongly favors DIRS over the general RNS fallback.
2017-11-29 English
Trading by management and of close relations to management
Director's Dealing Classification · 100% confidence The document title 'Transaktioner af ledende medarbejdere samt disses nærtstående' translates to 'Transactions by persons discharging managerial responsibilities and persons closely associated with them'. It explicitly references Article 19 of the EU Market Abuse Regulation (MAR), which is the standard regulatory requirement for reporting insider dealings. Since the document is a short announcement regarding these specific transactions, it falls under the 'Director's Dealing' category.
2017-11-29 Danish
Trading by management and of close relations to management
Director's Dealing Classification · 100% confidence The document is a formal notification of a share transaction by a person discharging managerial responsibilities (the CEO, Peder Holk Nielsen). It explicitly cites Regulation (EU) No 596/2014 (Market Abuse Regulation) and provides detailed tables of the transaction, including price, volume, and date. This fits the definition of a 'Director's Dealing' (DIRS) report, which covers insider trades by company executives.
2017-11-29 English
Transaction in Own Shares 2017
Transaction in Own Shares Classification · 100% confidence The document text is very short (169 characters) and states that Novozymes has completed its announced share buyback program ('tilbagekøb af B-aktier') up to DKK 2 billion during 2017. It explicitly directs the reader to 'Læs hele meddelelsen i PDF' (Read the full announcement in PDF). According to Rule #2 (The 'Menu vs Meal' Rule), a short announcement pointing to a full document suggests this is an announcement of an event or filing, not the detailed filing itself. The content specifically relates to the company buying back its own shares, which corresponds to the 'Transaction in Own Shares' definition (POS). Since this is a brief announcement about the completion of a share repurchase program, POS is the most appropriate classification.
2017-11-10 Danish
Transaction in Own Shares 2017
Transaction in Own Shares Classification · 98% confidence The document explicitly details transactions made under a stock buyback program, reporting the number of shares purchased, average price, and total transaction value for specific dates (November 6 to November 9, 2017). It concludes the program and reports the resulting treasury share count. This content directly relates to the company repurchasing its own shares. Therefore, the most appropriate classification is 'Transaction in Own Shares' (POS).
2017-11-10 English
Transaktioner i forbindelse med Novozymes’ aktietilbagekøbsprogram
Transaction in Own Shares Classification · 95% confidence The document is a brief announcement stating completion of the company’s share buyback program. This clearly relates to a repurchase of its own shares, fitting the definition of a 'Transaction in Own Shares' (POS).
2017-11-10 English

Browse filings by year

20 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.